FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to biotechnology and medicine. Offered is a vaccine composition containing immune-stimulating oligodeoxynucleic acid containing deoxyinosine residues (I - ODN) and antigens.
EFFECT: vaccine compositions elicit a more effective immune response in comparison with CpG sequence ODN and reduce induction of adverse reactions.
13 cl, 9 dwg, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| IMMUNOSTIMULATING OLIGODEOXYNUCLEOTIDES | 2001 |
|
RU2293573C2 |
| COMPLEX CONTAINING AN OLIGONUCLEOTIDE, HAVING IMMUNOSTIMULATING ACTIVITY, AND ITS APPLICATION | 2014 |
|
RU2723943C2 |
| VACCINE COMPOSITION | 2001 |
|
RU2328305C2 |
| ALLOGENEIC ANTITUMOR THERAPEUTIC MEDICATION | 2004 |
|
RU2354694C2 |
| VACCINATION USING THE ALPHA 3 DOMAIN OF MICA/B FOR CANCER TREATMENT | 2016 |
|
RU2747296C2 |
| IMMUNOSTIMULATORY OLIGONUCLEOTIDES | 2012 |
|
RU2610690C2 |
| MODIFIED SUPERCOILED PROTEINS WITH IMPROVED PROPERTIES | 2013 |
|
RU2677799C2 |
| METHODS OF TREATMENT OF DISEASES ASSOCIATED WITH HPV | 2019 |
|
RU2799784C2 |
| IMMUNOSTIMULATING OLIGONUCLEOTIDES | 2009 |
|
RU2477753C2 |
| COMPOSITION FOR TREATING PROSTATE CANCER | 2008 |
|
RU2583004C2 |
